Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9431)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2015 (publication date) through Jan 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stocco G, Cuzzoni E, Iudicibus SD, Favretto D, Malusà N, Martelossi S, Pozzi E, Lionetti P, Ventura A, Decorti G. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms. World J Gastroenterol 2015; 21(12): 3571-3578 [PMID: 25834322 DOI: 10.3748/wjg.v21.i12.3571] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i12/3571.htm |
| Number | Citing Articles |
| 1 |
Marianna Lucafò, Raffaella Franca, Davide Selvestrel, Debora Curci, Letizia Pugnetti, Giuliana Decorti, Gabriele Stocco. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(12): 1209 doi: 10.1080/17425255.2018.1551876
|
| 2 |
Boning Zeng, Shengnan Shi, Gareth Ashworth, Changjiang Dong, Jing Liu, Feiyue Xing. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death & Disease 2019; 10(4) doi: 10.1038/s41419-019-1540-2
|
| 3 |
Marianna Lucafò, Gabriele Stocco, Stefano Martelossi, Diego Favretto, Raffaella Franca, Noelia Malusà, Angela Lora, Matteo Bramuzzo, Samuele Naviglio, Erika Cecchin, Giuseppe Toffoli, Alessandro Ventura, Giuliana Decorti. Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants. Genes 2019; 10(4): 277 doi: 10.3390/genes10040277
|
| 4 |
Mária Kolesárová, Anita Vassová, Dana Marcinčáková, Ján Kyselovič, Andrea Gažová. Analysis of Crohn´s disease pharmacotherapy in the child and adult population. Klinická farmakologie a farmacie 2023; 37(2): 52 doi: 10.36290/far.2023.009
|
| 5 |
Gerassimos J. Mantzaris. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era. Current Treatment Options in Gastroenterology 2017; 15(1): 84 doi: 10.1007/s11938-017-0128-0
|
| 6 |
Siddharth Singh, Jihoon Kim, Wenhong Zhu, Parambir S. Dulai, William J. Sandborn, Vipul Jairath. No benefit of continuing vs stopping 5‐aminosalicylates in patients with ulcerative colitis escalated to anti‐metabolite therapy. Alimentary Pharmacology & Therapeutics 2020; 52(3): 481 doi: 10.1111/apt.15876
|
| 7 |
Yago González-Lama, Javier P Gisbert. Monitoring thiopurine metabolites in inflammatory bowel disease. Frontline Gastroenterology 2016; 7(4): 301 doi: 10.1136/flgastro-2015-100681
|
| 8 |
Dominic Picetti, Jihoon Kim, Wenhong Zhu, William J. Sandborn, Vipul Jairath, Siddharth Singh. No Benefit of Continuing 5-Aminosalicylates in Patients with Crohn’s Disease Treated with Anti-metabolite Therapy. Digestive Diseases and Sciences 2022; 67(7): 3115 doi: 10.1007/s10620-021-07301-x
|
| 9 |
Zohra Chadli, Ibtissem Hannachi, Manel Ben Belgacem, Arwa Guediche, Haifa Ben Romdhane, Emna Kerkeni, Lamia Hamdi, Ahlem Slama, Amel Chaabane, Nadia Ben Fredj, Naceur A Boughattas, Leila Safer, Karim Aouam. Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients. Pharmacogenomics 2024; 25(10-11): 441 doi: 10.1080/14622416.2024.2406739
|
| 10 |
Graziella Guariso, Marco Gasparetto. Treating children with inflammatory bowel disease: Current and new perspectives. World Journal of Gastroenterology 2017; 23(30): 5469-5485 doi: 10.3748/wjg.v23.i30.5469
|
| 11 |
Shobana John, Sommon Klumsathian, Paravee Own‐eium, Angkana Charoenyingwattana, Jakris Eu‐ahsunthornwattana, Thanyachai Sura, Donniphat Dejsuphong, Piyamitr Sritara, Prin Vathesatogkit, Nartthawee Thongchompoo, Wiphaporn Thabthimthong, Nuttinee Teerakulkittipong, Wasun Chantratita, Chonlaphat Sukasem. Thai pharmacogenomics database −2 (TPGxD‐2) sequel to TPGxD‐1, analyzing genetic variants in 26 non‐VIPGx genes within the Thai population. Clinical and Translational Science 2024; 17(10) doi: 10.1111/cts.70019
|
| 12 |
Kirsty M. Hooper, Peter G. Barlow, Craig Stevens, Paul Henderson. Inflammatory Bowel Disease Drugs: A Focus on Autophagy. Journal of Crohn's and Colitis 2017; 11(1): 118 doi: 10.1093/ecco-jcc/jjw127
|
| 13 |
Debbie M. Figueroa, Ender Karaca, Blake Atwood, Michele Erickson-Johnson. Clinical Decision Support for Pharmacogenomic Precision Medicine. 2022; : 53 doi: 10.1016/B978-0-12-824453-1.00006-3
|
| 14 |
Thandeka V.B. Malinga, Houcemeddine Othman, Maria Paximadis, Caroline T. Tiemessen, Michèle Ramsay, Scott Hazelhurst, David Twesigomwe. Characterization of NAT, GST, and CYP2E1 Genetic Variation in Sub‐Saharan African Populations: Implications for Treatment of Tuberculosis and Other Diseases. Clinical Pharmacology & Therapeutics 2025; doi: 10.1002/cpt.3557
|